CCG Investor Relations Announces Virtual Conference on NexGen Life Sciences September 12th, 2013

Event to cover breakthrough scientific developments that are transforming healthcare options and creating compelling investment themes

Jul 24, 2013, 09:00 ET from CCG Investor Relations

NEW YORK, July 24, 2013 /PRNewswire/ -- CCG Investor Relations ("CCG"), a leading US-headquartered global investor relations and strategic communications consultancy, today announced that it will hold a virtual conference on September 12th, 2013 on NexGen Life Sciences: Breakthrough Science, Exceptional Opportunities. The event is free to attend for investors at the website and is co-hosted by BetterInvesting, and PR Newswire on September 12th, 2013.

The NexGen Life Sciences Virtual Conference will focus on companies that employ breakthrough science to develop whole new classes of drugs, devices, therapies and diagnostic procedures. Through company presentations and expert panels, investors who are new to life sciences or experts in the field will obtain a wealth of insight on some of the defining trends in healthcare and be exposed to a range of new investment ideas.

The NexGen Life Sciences Virtual Conference provides public companies with the opportunity to broaden their marketing and investor education efforts to encompass retail investors and small funds that typically could not be reached cost-effectively.

The presenters and experts will cover a number of significant NexGen life science categories, including:

  • Molecular Diagnostics
  • Targeted Therapeutics  
  • Antibody Drug Conjugates
  • Stem Cell Therapies
  • Regenerative Medicine
  • Cancer Vaccines
  • Global CROs

The conference will feature three different expert panels, including:

  • Keynote speaker on "Transformative Therapies: The Next Decade of Innovation"
  • Analyst panel on "NexGen Drugs and Global CROs"
  • Analyst panel on "NexGen Devices and Diagnostics"
  • Banker panel on "Corporate Finance Alternatives for Emerging Life Sciences Companies"

"This NexGen Life Sciences Virtual Conference will provide investors with a road map as to how scientific breakthroughs move through the process towards commercialization, including FDA trials, partnerships, distribution agreements and insurance code approvals. This panel will provide both institutional and retail investors with insights from leading analysts as to some of the ways that investors can benefit from the very significant rise in the industry. For life science executives, this is a chance to tell your story to a broad array of institutional and retail investors," said Mr. Crocker Coulson, President of CCG Investor Relations.

"We are very excited to be expanding the scope of our virtual conference series into life science, following the very successful event on The Shale Revolution in July, which has attracted nearly 1,000 investor visitors thus far."

In addition to the live event, the archived presentation will provide an effective tool for ongoing communication to interested individuals. Hosted by some of the top names in financial news and retail investor communication, the event is backed by a unique set of marketing skills and reach.

Companies that are interested in presenting at this virtual conference can contact Crocker Coulson, president of CCG Investor Relations, at 646-213-1915 or

The virtual conference is free for investors to attend and you can pre-register for the event by going to

About the Monthly Virtual Investment Conferences:

Co-hosted by BetterInvesting, CNW-Canada Newswire and PR Newswire, the Monthly Virtual Investment Conference Series is designed to provide an interactive and convenient platform for retail and institutional investors to communicate with public companies. Built on a robust Webinar system and focused on specific sectors, the Virtual Conferences include company presentations, expert panels and Q&As where investors can obtain first-hand experience in learning issuers' investment stories, industry dynamics, stock recommendations and investment strategies. All the Virtual Conferences are free for investors to attend.

About CCG Investor Relations:

CCG is a leading global investor relations and strategic communications consulting firm. In business for more than 30 years, the agency provides a complete range of investor relations, strategic communications and consulting services to both public and private companies across multiple capital markets. CCG has been awarded a number of industry honors for its handling of complex investor relations and crisis communications matters. The agency's corporate headquarters is in Los Angeles with additional offices in New York, Beijing, London and Tel Aviv.

For further information, contact CCG directly, or visit the Company's web sites at


Crocker Coulson, President, CCG Investor Relations
Tel: +1-646-213-1915

SOURCE CCG Investor Relations